Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
The Journal of Rheumatology. Supplement|November 19, 2002
Key randomized trials of single agents in early rheumatoid arthritisLeo B A van de PutteLancet (London, England)|April 17, 2002
Research in complex diseasesNiek de Vries, Piet L C M van Riel, Leo B A van de PutteArthritis and Rheumatism|April 16, 2002
Reshaping the shared epitope hypothesis: HLA-associated risk for rheumatoid arthritis is encoded by amino acid substitutions at positions 67-74 of the HLA-DRB1 moleculeNiek de Vries, Henk Tijssen, Piet L C M van Riel, et al.The Journal of Rheumatology|May 8, 2003
Role of Fcgamma receptors IIA, IIIA, and IIIB in susceptibility to rheumatoid arthritisTimothy R D J Radstake, Elisabeth Petit, Cieline Pierlot, et al.The Journal of Rheumatology|September 9, 2006
Intranasal administration of recombinant human cartilage glycoprotein-39. A phase I escalating cohort study in patients with rheumatoid arthritisMichiel M Zandbelt, Jos G A Houbiers, Frank H J van den Hoogen, et al.Clinical and Experimental Rheumatology|February 25, 2011
Effects of naproxen and sulphasalazine or methotrexate on hypothalamic-pituitary-adrenal axis activity in patients with rheumatoid arthritisAgnes M M Eijsbouts, Marlies J E Kempers, Frank H J van den Hoogen, et al.British Journal of Clinical Pharmacology|January 10, 2009
Effect of naproxen on the hypothalamic-pituitary-adrenal axis in healthy volunteersAgnes M M Eijsbouts, Marlies J E Kempers, Renske S A Kramer, et al.Annals of the Rheumatic Diseases|September 26, 2009
Intranasal administration of recombinant human cartilage glycoprotein-39 as a treatment for rheumatoid arthritis: a phase II, multicentre, double-blind, randomised, placebo-controlled, parallel-group, dose-finding trialRobert B M Landewé, Jos G A Houbiers, Filip Van den Bosch, et al.Pageof 1